Matthew Halma (@MatthewHalma) profile picture

Biophysicist | #Postviral syndromes, #longCOVID, #PACVS | Open Source Medicine Foundation | https://teapawt.net/t.co/kWFDPz3ED2

Joined October 2022
Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)Photo by Matthew Halma (@MatthewHalma)
1/ Long COVID and post-acute COVID-19 vaccination syndrome (PACVS) share the same core picture: fatigue, brain fog, post-exertional malaise, dysautonomia. No routine clinical test separates them. What does the biomarker research show? 🧵 Fig: Purpura et al., Clin Infect Dis 2026 (CC BY-NC-ND 4.0)
2
10
2
46
2,409
Matthew Halma retweeted
わかったような帯グラフがありますけど、実際には何にもわかってない状態で、世界中で拡大接種を決行したんですな。 血中単球が持続的にスパイクタンパクを保持するのも後からわかったんだし。
Replying to @MatthewHalma
8/ Spike persistence. Patterson et al. (HV&I 2025) studied 50 PCVS patients with no evidence of prior infection. In a subset tested by flow cytometry (n=12), they reported S1 in CD16+ monocytes up to 245 days after vaccination, plus raised sCD40L, CCL5, IL-6 and IL-8. The same group had earlier reported S1 persistence after infection. Fig: Patterson 2025 Fig 4 (CC BY-NC 4.0)
1
4
99
I've been reading published studies of neurotransmitter differences in long COVID versus comparison groups. The most consistent finding is reduced GABA-B inhibition on TMS. Two 2026 papers now point to catecholamines, while peripheral serotonin is still contested. #LongCOVID
1
2
5
291
I've been reading published studies of neurotransmitter differences in long COVID versus comparison groups. The most consistent finding is reduced GABA-B inhibition on TMS. Two 2026 papers now point to catecholamines, while peripheral serotonin is still contested. #LongCOVID
1
1
15
941
Kynurenines came up in the last thread. Cysique 2023 saw early rises vs reference ranges. Matits 2026 (127 vs 91) found associations, not a clear difference. Almulla 2024: lower tryptophan (SMD −0.52) and higher KYN/TRP (SMD 0.76). doi.org/10.1016/j.jpsychores… doi.org/10.1016/j.neuroscien…
1
40
I found no neurotransmitter study in PACVS — a gap, not evidence of no difference. Next: independent replication of the 2026 PET and CSF findings, and serotonin assays that handle platelets and SSRI use carefully. Observational only. #LongCOVID #PACVS #LakshmiPriya
130
Matthew Halma retweeted
DocuSign wants $8,100/yr from a 15-person team just to sign PDFs. So I built SignuDoc: open source, one-click deploy to your own @vercel account, $0 per seat. White-label branding, full audit trails, tamper-evident seals and your documents never leave your cloud.
989
1,778
458
29,210
4,104,407
In this video I walk through published metabolomic studies of blood metabolites in long COVID versus healthy controls. Similar exercise intolerance has been described in PACVS, but dedicated metabolomic datasets are still few. youtube.com/watch?v=iJY2p51Y… #LongCOVID #PACVS
3
2
20
724
PACVS shows overlapping exercise findings, but we still have very few dedicated metabolomic datasets. Open questions for me are how common these signatures are outside selected cohorts, and whether the metabolites move as symptoms change. Head-to-head studies would help.
1
14